Trial Profile
Retrospective, single-center study comparing the effect of treatment Azacitidine with Low-dose cytarabine in patients with acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary) ; Cytarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 01 Dec 2015 New trial record